Cargando…

Considerations for Evaluating the Introduction of New Cancer Screening Technology: Use of Interval Cancers to Assess Potential Benefits and Harms

This framework focuses on the importance of the consideration of the downstream intermediate and long-term health outcomes when a change to a screening program is introduced. The authors present a methodology for utilising the relationship between screen-detected and interval cancer rates to infer t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farber, Rachel, Houssami, Nehmat, Barnes, Isabelle, McGeechan, Kevin, Barratt, Alexandra, Bell, Katy J. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691207/ https://www.ncbi.nlm.nih.gov/pubmed/36429373 http://dx.doi.org/10.3390/ijerph192214647

Ejemplares similares

Impact of Full-Field Digital Mammography Versus Film-Screen Mammography in Population Screening: A Meta-Analysis
por: Farber, Rachel, et al.
Publicado: (2020)

Informing Women About Overdetection in Breast Cancer Screening: Two-Year Outcomes From a Randomized Trial
por: Hersch, Jolyn, et al.
Publicado: (2021)

How information about overdetection changes breast cancer screening decisions: a mediation analysis within a randomised controlled trial
por: Hersch, Jolyn, et al.
Publicado: (2017)

The effect of information about overdetection of breast cancer on women's decision-making about mammography screening: study protocol for a randomised controlled trial
por: Hersch, Jolyn, et al.
Publicado: (2014)

Evidence of potential overdiagnosis and overtreatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents: protocol for a scoping review
por: Kazda, Luise, et al.
Publicado: (2019)

Association of Attention-Deficit/Hyperactivity Disorder Diagnosis With Adolescent Quality of Life
por: Kazda, Luise, et al.
Publicado: (2022)

Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Systematic Scoping Review
por: Kazda, Luise, et al.
Publicado: (2021)

The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening
por: Houssami, Nehmat, et al.
Publicado: (2017)

The potential for overdiagnosis and underdiagnosis because of blood pressure variability: a comparison of the 2017 ACC/AHA, 2018 ESC/ESH and 2019 NICE hypertension guidelines
por: Bell, Katy, et al.
Publicado: (2021)

Evaluating two decision aids for Australian men supporting informed decisions about prostate cancer screening: A randomised controlled trial
por: Pickles, Kristen, et al.
Publicado: (2020)

Overdiagnosis of breast cancer in population screening: does it make breast screening worthless?
por: Houssami, Nehmat
Publicado: (2017)

Can population breast screening programs be leveraged to reduce the burden of breast cancer?
por: Houssami, Nehmat
Publicado: (2021)

Women’s views on overdiagnosis in breast cancer screening: a qualitative study
por: Hersch, Jolyn, et al.
Publicado: (2013)

Screening women with a personal history of breast cancer: overview of the evidence on breast imaging surveillance
por: Houssami, Nehmat, et al.
Publicado: (2018)

Reflections from Women with an Interval Breast Cancer Diagnosis: A Qualitative Analysis of Open Disclosure in the BreastScreen Western Australia Program
por: Claringbold, Lily, et al.
Publicado: (2023)

Overdetection in breast cancer screening: development and preliminary evaluation of a decision aid
por: Hersch, Jolyn, et al.
Publicado: (2014)

Staging the axilla in women with breast cancer: the utility of preoperative ultrasound-guided needle biopsy
por: Houssami, Nehmat, et al.
Publicado: (2014)

Evidence from a BreastScreen cohort does not support a longer inter-screen interval in women who have no conventional risk factors for breast cancer
por: Noguchi, Naomi, et al.
Publicado: (2022)

Should women aged 70–74 be invited to participate in screening mammography? A report on two Australian community juries
por: Degeling, Chris, et al.
Publicado: (2018)

Cancer immunotherapy: Benefit and harm?
por: Characiejus, Dainius
Publicado: (2012)

Effect of implementing digital breast tomosynthesis (DBT) instead of mammography on population screening outcomes including interval cancer rates: Results of the Trento DBT pilot evaluation
por: Bernardi, Daniela, et al.
Publicado: (2019)

Artificial intelligence (AI) in breast cancer care - Leveraging multidisciplinary skills to improve care()
por: Cardoso, Maria Joao, et al.
Publicado: (2020)

Interval breast cancer rates for digital breast tomosynthesis versus digital mammography population screening: An individual participant data meta-analysis
por: Houssami, Nehmat, et al.
Publicado: (2021)

Ambulatory blood pressure adds little to Framingham Risk Score for the primary prevention of cardiovascular disease in older men: secondary analysis of observational study data
por: Bell, Katy J L, et al.
Publicado: (2014)

Legacy effects of statins on cardiovascular and all-cause mortality: a meta-analysis
por: Nayak, Agnish, et al.
Publicado: (2018)

Towards consensus on managing high mammographic density in population breast screening?
por: Tagliafico, Alberto Stefano, et al.
Publicado: (2023)

Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women
por: van Ravesteyn, Nicolien T, et al.
Publicado: (2021)

Rates of reoperation after breast conserving cancer surgery in Western Australia before and after publication of the SSO-ASTRO margins guideline
por: Marinovich, M. Luke, et al.
Publicado: (2023)

Pathways to breast cancer screening artificial intelligence algorithm validation
por: Lee, Christoph I., et al.
Publicado: (2019)

Media Coverage of the Benefits and Harms of Testing the Healthy: a protocol for a descriptive study
por: O'Keeffe, Mary, et al.
Publicado: (2019)

Factor influencing women with learning disabilities deciding to, and accessing, cervical and breast cancer screening: Findings from a Q methodology study of women with learning disabilities, family and paid carers
por: Sykes, Kate, et al.
Publicado: (2022)

Overview of radiomics in breast cancer diagnosis and prognostication
por: Tagliafico, Alberto Stefano, et al.
Publicado: (2019)

Who Uses Smoking Cessation Apps? A Feasibility Study Across Three Countries via Smartphones
por: BinDhim, Nasser F, et al.
Publicado: (2014)

Assessing the effect of an interactive decision-aid smartphone smoking cessation application (app) on quit rates: a double-blind automated randomised control trial protocol
por: BinDhim, Nasser F, et al.
Publicado: (2014)

Smartphone Smoking Cessation Application (SSC App) trial: a multicountry double-blind automated randomised controlled trial of a smoking cessation decision-aid ‘app’
por: BinDhim, Nasser F, et al.
Publicado: (2018)

The ethical, legal and social implications of using artificial intelligence systems in breast cancer care
por: Carter, Stacy M., et al.
Publicado: (2019)

A population-based study of breast cancer prevalence in Australia: predicting the future health care needs of women living with breast cancer
por: Yu, Xue Qin, et al.
Publicado: (2014)

Artificial intelligence (AI) for breast cancer screening: BreastScreen population-based cohort study of cancer detection
por: Marinovich, M. Luke, et al.
Publicado: (2023)

Breast cancer Ki-67 expression prediction by digital breast tomosynthesis radiomics features
por: Tagliafico, Alberto Stefano, et al.
Publicado: (2019)

An assessment of the relationship between clinical utility and predictive ability measures and the impact of mean risk in the population
por: McGeechan, Kevin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m55t2t21i0fd57fh0vh8mt9ano